Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
OMEGA PACIFIC RESOURCES | Q0F | 30. sep 2024 | 0.12 | +1.72 |
Omer S.p.a | 9WR | 30. sep 2024 | 4.35 | +1.64 |
Omer-Decugis & Cie | 0VC | 30. sep 2024 | 4.12 | -1.44 |
Omeros Corporation | 3O8 | 30. sep 2024 | 3.53 | +1.79 |
Omni Bridgeway Limited | MXG1 | 30. sep 2024 | 0.69 | 0.00 |
Omnia Holdings Ltd | OHZ | 30. sep 2024 | 3.38 | +3.68 |
Omnicell, Inc. | OC9 | 30. sep 2024 | 38.00 | -0.52 |
Omnicom Group Inc. | OCN | 30. sep 2024 | 92.24 | 0.00 |
OMV AG | OMV | 30. sep 2024 | 38.20 | +1.87 |
OMV AG | OMVI | 30. sep 2024 | 9.25 | +2.21 |
ON Semiconductor Corporation | XS4 | 30. sep 2024 | 66.08 | -0.24 |
On the Beach Group plc | 9BP | 30. sep 2024 | 1.65 | -0.60 |
Oncimmune Holdings plc | OCY | 30. sep 2024 | 0.15 | 0.00 |
Oncoarendi Therapeutics SA | 1B1 | 30. sep 2024 | 3.15 | +2.44 |
ONCODES.PREC.MED. EO-,34 | ZR8 | 30. sep 2024 | 0.99 | +4.22 |
Onconova Therapeutics, Inc. | 0T2 | 30. sep 2024 | 6.60 | 0.00 |
Oncopeptides | OND | 30. sep 2024 | 0.13 | -25.82 |
Oncotherpapy Science Inc | 30O | 30. sep 2024 | 0.19 | -3.08 |
OncoZenge | 8LY | 30. sep 2024 | 0.56 | +4.28 |
ONDAS HLDGS INC. DL-,0001 | 1B8 | 30. sep 2024 | 0.60 | 0.00 |
Onde S.A. | 0XF | 30. sep 2024 | 2.52 | +0.40 |
Ondine Biomedical Inc | VF5 | 30. sep 2024 | 0.06 | 0.00 |
ONE Gas, Inc. | OG9 | 30. sep 2024 | 65.50 | 0.00 |
One Liberty Properties, Inc. | O1A | 30. sep 2024 | 24.40 | +0.83 |
One Media iP Group Plc | 1M9 | 30. sep 2024 | 0.04 | 0.00 |
One More Level S.A. | 1OJ | 30. sep 2024 | 0.34 | +3.17 |
One Stop Systems, Inc. | 5MU | 30. sep 2024 | 2.08 | +4.52 |
OneApex Limited | CWF | 30. sep 2024 | 0.08 | 0.00 |
ONEFLOW AB | L58 | 30. sep 2024 | 3.29 | +2.17 |
OneMain Holdings, Inc. | 0S1 | 30. sep 2024 | 41.59 | +0.14 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.